Published in Clin Exp Immunol on April 02, 2017
Murine Models of Transplantation Tolerance through Mixed Chimerism: Advances and Roadblocks. Clin Exp Immunol (2017) 0.83
Immune tolerance in transplantation. Clin Exp Immunol (2017) 0.75
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest (2003) 4.14
Malignant lymphomas in transplantation patients. Transplant Proc (1969) 4.12
Homeostatic proliferation is a barrier to transplantation tolerance. Nat Med (2003) 4.12
Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant (2004) 4.04
Solid organ allograft survival improvement in the United States: the long-term does not mirror the dramatic short-term success. Am J Transplant (2011) 3.52
IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest (2007) 3.31
Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Sci Transl Med (2012) 3.27
Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 3.18
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood (2012) 2.72
CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates. Am J Transplant (2004) 2.45
De-novo brain tumours in renal-transplant recipients. Lancet (1971) 2.36
Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol (2004) 1.93
Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation (2002) 1.86
Heterologous immunity: an overlooked barrier to tolerance. Immunol Rev (2003) 1.76
Cardiovascular toxicities of immunosuppressive agents. Am J Transplant (2002) 1.71
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest (2004) 1.63
On the immunocompetence of H-2 incompatible irradiation bone marrow chimeras. J Immunol (1980) 1.62
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Plasmacytoid precursor dendritic cells facilitate allogeneic hematopoietic stem cell engraftment. J Exp Med (2005) 1.53
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression. Am J Transplant (2014) 1.49
Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood (1994) 1.49
CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis. Proc Natl Acad Sci U S A (2011) 1.47
Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Am J Transplant (2014) 1.44
Molecular mechanisms of treg-mediated T cell suppression. Front Immunol (2012) 1.41
Mixed allogeneic chimerism as an approach to transplantation tolerance. Immunol Today (1988) 1.33
Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood (2010) 1.33
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2013) 1.29
Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med (1989) 1.29
Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant (2011) 1.20
Chimerism, graft survival, and withdrawal of immunosuppressive drugs in HLA matched and mismatched patients after living donor kidney and hematopoietic cell transplantation. Am J Transplant (2015) 1.15
Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl (1998) 1.13
Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation (2011) 1.12
Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation (2000) 1.09
Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf (1997) 0.99
The metabolic effects of cyclosporin and tacrolimus. J Endocrinol Invest (2001) 0.99
Kidney. Am J Transplant (2016) 0.94
Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates. Transplantation (2006) 0.91
Tolerance of Lung Allografts Achieved in Nonhuman Primates via Mixed Hematopoietic Chimerism. Am J Transplant (2015) 0.88
High cyclosporin levels after bone marrow transplantation associated with hypertriglyceridaemia. Lancet (1986) 0.86
A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation. Hepatology (2016) 0.84
Nonchimeric HLA-Identical Renal Transplant Tolerance: Regulatory Immunophenotypic/Genomic Biomarkers. Am J Transplant (2015) 0.84
Effect of cyclosporine on plasma lipids and modification with dietary fish oil. Transplantation (1988) 0.83
Long-term lung transplantation in nonhuman primates. Am J Transplant (2015) 0.83
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. Transplantation (1998) 0.80
Cardiovascular risk profile with the new immunosuppressive combinations after renal transplantation. J Hypertens (2005) 0.80
Effect of ex vivo Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques. Transplantation (2016) 0.80
Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group. Transplant Proc (1995) 0.76
Effect of tolerance versus chronic immunosuppression protocols on the quality of life of kidney transplant recipients. JCI Insight (2016) 0.75
The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques. Am J Transplant (2016) 0.75
Induced regulatory T cells in allograft tolerance via transient mixed chimerism. JCI Insight (2016) 0.75
T-cell immunoincompetence in allogeneic chimerism. N Engl J Med (1992) 0.75